UTHR News Alert United Therapeutics Corp (UTHR) 126.04 12/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
United Therapeutics Corp (UTHR) 126.04 $UTHR

Additions/deletions from Nasdaq's Q-50 Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 6:54AM CST

GLNG: 31.44 (-1.83), MXIM: 30.48 (-0.16), ODFL: 76.21 (-1.19), NUAN: 13.81 (-0.22), UTHR: 126.04 (-2.81), FSLR: 40.90 (-0.76), QQQ: 99.98 (-1.63), ALNY: 92.08 (-1.87), SCTY: 49.77 (+0.13), SHPG: 208.76 (+0.28), MPEL: 22.21 (-0.94), EXPE: 86.04 (-1.29), FFIV: 128.27 (-1.99), SSYS: 79.07 (-4.84), CAR: 55.83 (-1.76), JD: 23.13 (-0.13), SPLK: 53.75 (-1.12), MELI: 127.00 (-7.28), MEOH: 44.22 (+0.99), CREE: 30.03 (-0.24)

Quarterly Changes to the NXTQ Index
GlobeNewswire - Mon Dec 15, 6:20AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the quarterly re-ranking of the NASDAQ Q-50 Index (Nasdaq:NXTQ), which will become effective prior to market open on Monday, December 22, 2014.
MXIM: 30.48 (-0.16), ODFL: 76.21 (-1.19), EA: 45.45 (unch), UTHR: 126.04 (-2.81), ALNY: 92.08 (-1.87), SCTY: 49.77 (+0.13), SHPG: 208.76 (+0.28), SSYS: 79.07 (-4.84), FFIV: 128.27 (-1.99), MPEL: 22.21 (-0.94), AAL: 47.96 (-2.88), CAR: 55.83 (-1.76), NWS: 14.24 (-0.01), MEOH: 44.22 (+0.99), CREE: 30.03 (-0.24), GLNG: 31.44 (-1.83), NUAN: 13.81 (-0.22), FSLR: 40.90 (-0.76), LRCX: 76.84 (-1.49), EXPE: 86.04 (-1.29), SPLK: 53.75 (-1.12), JD: 23.13 (-0.13), MELI: 127.00 (-7.28), NDAQ: 45.74 (-0.72)

United Therapeutics: Will It Pass Peers In 2015?
at Investor's Business Daily - Fri Dec 12, 5:11PM CST
Biomed company United Therapeutics is in a strong industry group, and that's a problem. United Therapeutics' (UTHR) three-year earnings growth rate is 26%, good enough for an EPS Rating of 89. However, in a leading group, "good enough" isn't good...
BIIB: 325.13 (-10.67), UTHR: 126.04 (-2.81), ALXN: 177.73 (-5.48), TEVA: 55.15 (-0.47), CELG: 110.09 (-1.79)

Can United Therapeutics find a remedy for recent resistance?
at Investor's Business Daily - Thu Dec 11, 10:48AM CST
Today we'll look at United Therapeutics (UTHR), which develops therapies to treat pulmonary arterial hypertension, cancer and some of the most complicated viral diseases. Key Fundamentals After a sharp decline in earnings growth for several quarters,...
UTHR: 126.04 (-2.81)

Downgrade Alert for United Therapeutics (UTHR)
Comtex SmarTrend(R) - Thu Dec 11, 7:05AM CST
United Therapeutics (NASDAQ:UTHR) was downgraded from Neutral to Underperform at Credit Suisse today. The stock closed yesterday at $131.51 on volume of 653,000 shares, below average daily volume of 670,000. Based on a current price of $131.51, United Therapeutics is currently 3.7% above its average consensus analyst price target of $126.62. The stock should discover initial support at its 50-day moving average (MA) of $128.48 and subsequent support at its 200-day MA of $106.56.
UTHR: 126.04 (-2.81)

Stocks Fall To Session Lows: GoPro Gives Up More Ground
at Investor's Business Daily - Mon Dec 08, 12:25PM CST
Stocks were near session lows in early afternoon trading as oil prices fell hard again. The Nasdaq lost 0.5%, the S&P 500 fell 0.4% and the Dow Jones industrial average gave up 0.4% also. Nasdaq and NYSE volume was tracking slightly higher than...
AMBA: 45.78 (-0.35), GPRO: 58.27 (+1.27), CBST: 96.73 (+0.42), GILD: 100.46 (-2.70), MRK: 56.80 (-0.15), UTHR: 126.04 (-2.81), MCD: 88.72 (+0.26), REGN: 396.13 (-4.88), CELG: 110.09 (-1.79)

Actelion submits MAA for pulmonary hypertension drug
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 2:36PM CST

MSTX: 0.45 (+0.01), GILD: 100.46 (-2.70), UTHR: 126.04 (-2.81), GSK: 41.92 (+0.62), ARNA: 3.78 (+0.06)

Actelion Submits Marketing Application for Uptravi in EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 2:10PM CST
Actelion Ltd. (ALIOF) submitted a centralized marketing authorization application to the European Medicines Agency for its PAH candidate, Uptravi (selexipag).
BIIB: 325.13 (-10.67), UTHR: 126.04 (-2.81)

Stock Market Today: Top Biotech Is Near Buy Point
at Investor's Business Daily - Wed Nov 26, 4:40PM CST
Many leading stocks have risen out of buying range since a new market uptrend began last month, but a number are still working on bases. United Therapeutics (UTHR), which develops treatments for cardiovascular and infectious diseases as well as for...
UTHR: 126.04 (-2.81), GIII: 94.02 (-0.90), CAR: 55.83 (-1.76), CP: 182.52 (+4.71)

United Therapeutics Earnings In Retrospect: Down 3.9% in the Last 20 Days (UTHR)
Comtex SmarTrend(R) - Mon Nov 17, 3:24PM CST
20 days ago, on October 28th, 2014, United Therapeutics (NASDAQ:UTHR) reported its earnings. Analysts, on average, expected earnings of $2.75 per share on sales of $335.1 million. The company actually reported EPS of $3.91 on sales of $330.0 million, beating EPS estimates by $1.16 and missing revenue estimates by $5.2 million. Since the company's report, shares of United Therapeutics have fallen from $130.49 to $125.43, representing a loss of 3.9% in the past 20 days.
UTHR: 126.04 (-2.81)

United Therapeutics appoints Professor Katherine J. Klein to board
M2 - Thu Nov 13, 7:08AM CST
Biotechnology company United Therapeutics (NasdaqGS:UTHR) stated on Thursday that Professor Katherine J. Klein, PhD has been elected as an independent director to its board of directors with effect from 11 November 2014.
UTHR: 126.04 (-2.81)

Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors
PR Newswire - Thu Nov 13, 5:00AM CST
United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Professor Katherine J. Klein, Ph.D., of The Wharton School of the University of Pennsylvania to its Board of Directors as an independent director. The appointment is effective as of November 11, 2014.
UTHR: 126.04 (-2.81), SCHW: 28.12 (-0.62)

United Therapeutics Earnings In Retrospect: Down 4.8% in the Last 13 Days (UTHR)
Comtex SmarTrend(R) - Mon Nov 10, 12:57PM CST
When United Therapeutics (NASDAQ:UTHR) reported earnings a week ago on October 28th, 2014, analysts, on average, expected the company to report earnings of $2.75 on sales of $335.1 million. United Therapeutics actually reported earnings of $3.91 per share on sales of $330.0 million, beating EPS estimates by $1.16 and missing revenue estimates by $5.2 million. Shares of United Therapeutics have slipped from $130.49 to $124.21, representing a loss of 4.8%, since the company reported earnings 13 days ago.
UTHR: 126.04 (-2.81)

Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion
PR Newswire - Fri Oct 31, 7:40AM CDT
Today, Analysts Review released its research reports regarding Receptos Inc. (NASDAQ: RCPT), Wright Medical Group Inc. (NASDAQ: WMGI), United Therapeutics Corporation (NASDAQ: UTHR), Abbott Laboratories (NYSE: ABT) and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7594-100free.
ABT: 43.40 (-0.06), WMGI: 27.22 (-0.40), CFN: 58.65 (-0.07), UTHR: 126.04 (-2.81), RCPT: 114.46 (-0.67), WMGIZ: 4.30 (+0.08)

Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert
Marketwired - Fri Oct 31, 5:15AM CDT
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There are more than 1,400 active reported Pharmaceutical-Biotech capital and maintenance (MRO) projects in North America, representing a total investment value (TIV) of nearly $62 billion. According to a recent analysis of Industrial Info's Pharmaceutical-Biotech Industry database, the Mid-Atlantic region is at the top of that investment, accounting for an $8.5 billion portion of that spending divided over 176 projects.
UTHR: 126.04 (-2.81)


Apple CEO publicly acknowledges that he's gay
By MAE ANDERSON - AP - Thu Oct 30, 6:59PM CDT
NEW YORK (AP) — Apple CEO Tim Cook's declaration that he's "proud to be gay" wasn't exactly news in Silicon Valley, where his sexual orientation was no secret. But advocates say that given Apple's immense reach and visibility, his coming-out could help change attitudes in workplaces across America.
UTHR: 126.04 (-2.81), AEO: 13.09 (-0.39), AAPL: 106.75 (-1.47)

United Therapeutics Sells Off On Good News - Why I Bought That Dip
DoctoRx - Seeking Alpha - Thu Oct 30, 2:52PM CDT
Background : The smallish biotech/biopharma company United Therapeutics (NASDAQ: UTHR ) is a favorite of mine on its own merits and as a takeover play. The company has a steadfast focus on the fatal orphan disease known as PAH (pulmonary arterial...
MDT: 71.34 (-0.65), GILD: 100.46 (-2.70), UTHR: 126.04 (-2.81), SUPN: 8.72 (+0.08), AMGN: 159.44 (-0.16), GSK: 41.92 (+0.62)

United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:02AM CDT
United Therapeutics Corporation (UTHR) incurred a third-quarter loss of 53 cents per share, missing the Zacks Consensus Estimate by a wide margin.
LCI: 42.70 (-1.35), MDT: 71.34 (-0.65), UTHR: 126.04 (-2.81), NVS: 91.65 (+0.01)

Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin
PR Newswire - Wed Oct 29, 7:40AM CDT
Investor-Edge has initiated coverage on the following equities: NewLink Genetics Corporation (NASDAQ: NLNK), Biogen Idec Inc. (NASDAQ: BIIB), United Therapeutics Corporation (NASDAQ: UTHR), Dynavax Technologies Corporation (NASDAQ: DVAX), and Amarin Corporation PLC (NASDAQ: AMRN). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, October 28, 2014, the NASDAQ Composite ended at 4,564.29, up 1.75%, the Dow Jones Industrial Average advanced 1.12%, to finish the day at 17,005.75, and the S&P 500 closed at 1,985.05, up 1.19%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index also advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
DVAX: 14.34 (-0.03), BIIB: 325.13 (-10.67), AMRN: 1.03 (-0.02), UTHR: 126.04 (-2.81), NLNK: 33.10 (-0.36)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 21

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 319

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 114

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 142

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 191

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Ryan Specialty Group's Strategic Push with Innovisk Acquisition

Updated Category News Views 151

Ryan Specialty Group's Acquisition Strategy Ryan Specialty Group (NYSE: RYAN), a prominent player in the specialty insurance sector, is on the brink of finalizing its acquisition of Innovisk Capital Partners. This move is primarily aimed at bolstering their underwriting capacity and expanding their overall market presence. The anticipated completion of the transaction is...

Continue Reading
Stifel Adjusts Align Technology Target Amid Restructuring Plans

Updated Category News Views 216

Stifel Adjusts Align Technology Target Price Recently, Stifel revised its outlook on Align Technology (NASDAQ: ALGN), lowering the price target from $285 to $275 while maintaining a Buy rating on the stock. This adjustment reflects the company's third-quarter financial performance, which met the expectations outlined in the analyst's prior survey. Performance Overview The...

Continue Reading
Golf Scramble Fundraiser to Empower Chicago's Youth Programs

Updated Category News Views 161

Golf Scramble Fundraiser to Empower Youth Nonprofit organization buildOn is excited to announce its inaugural Drive for Students Golf Scramble, a unique fundraiser focused on uniting students through service and education. This event is dedicated primarily to empowering young individuals and providing them the necessary tools to make a lasting impact in their communities....

Continue Reading
Key Highlights from Last Year's Most Notable Releases

Updated Category News Views 255

Overview of Press Releases That Made an Impact The past year was filled with significant announcements and updates that captured audience interest across various sectors. From recalls to growth strategies, the stories represented a multitude of companies and their evolving narratives. Top Press Releases of the Year Some highlights from the most widely read releases over...

Continue Reading
Thomas 'Biz Doc' Ellsworth Joins the Private Economic Council

Updated Category News Views 173

Thomas 'Biz Doc' Ellsworth Joins the Private Economic Council The Private Economic Council (PEC), a coalition of prominent economists, entrepreneurs, and policy makers, has welcomed Thomas Ellsworth to its influential roster. This news highlights Ellsworth's perceived value amidst a team dedicated to fostering economic growth. Experience and Background Ellsworth, known as...

Continue Reading